The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.
The provision of all healthcare is becoming an interdisciplinary activity, and it is increasingly important that the different parties in care connect to each other for the benefit of the patient. This is also valid for pharmaceutical care. All different elements of the care around medicines should be coordinated between the different professionals such as pharmacists, doctors, nurses and of course the patient. In practice this is not yet happening, and it affects the quality of the care.
We were therefore glad to see more then 90 participants at the 8th PCNE Working Conference in Berlin, who wanted to contribute to the research and implementation of collaborative pharmaceutical care.
Prof. Dr. Kurt Hersberger,
The slides of the lectures and reports of the workshops will gradually appear on these pages.
PCNE gratefully acknowledges support from following sponsors:
The PCNE working Conference has been accredited for Dutch participants (community pharmacists) for 17 continuing education hours.
Charlotte Rossing, Denmark; Maria Cordina, Malta; Mary Tully, United Kingdom; Nina Griese, Germany; Veerle Foulon, Belgium; Foppe van Mil, the Netherlands; Kurt Hersberger, Switzerland (Chair); Olivier Bugnon, Switzerland.
(Facilitators Foppe van Mil, the Netherlands and Saija Leikola, Finland)
• Aim: To merge the results of previous PCNE Medication Review workshops and create a manual or guidelines for optimal medication review procedures that can be used in pharmaceutical care in different countries.
(Facilitators Maria Cordina, Malta and Tommy Westerlund, Sweden)
• Aim: To discuss and develop guidance on best practice in designing and conducting interdisciplinary research projects that evaluate interprofessional service delivery.
(Facilitators: Alison Roberts, Australia and Charlotte Rossing, Denmark)
• Aim: (1) To explore the various strategies used for implementing pharmaceutical care services, gaining an understanding of those that increase the chances of sustainable change and (2) To design indicators that can be applied in practice and used in research, to measure the successful implementation of pharmaceutical care services and collaborative practice.
(Facilitators Olivier Bugnon & Marie-Paul Schneider, Switzerland and Martin Henman, Ireland)
• Aim: To develop a system for assuring quality of research and the research group, involving different professionals
(Facilitators: Veerle Foulon and Giannoula Tsakitzidis, Belgium, Maria Cordina, Malta)
• Aim: To develop a framework and teaching methodologies, and to prepare practitioners to contribute to interprofessional research and practice, so that different professionals will cooperate better in their future.
Accepted abstracts,sorted by last name of submitting author. Klick on the abstract title to download a pdf.
The pdf's of the full presentations of the oral communications can be found under the tab 'Lectures'.
|53||Consequences of drug-related problems||Agaard Thomsen||Denmark|
|9||Choosing a method for validating prescribing appropriateness criteria||Basger||Australia|
|10||Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method||Basger||Australia|
|17||Medication review at the general practitioners' office - a multi-disciplinary approach in ambulatory care (Oral communication)||Blix||Norway|
|19||Electronic multidrug punch cards for patients after hospital discharge - a Study design||Boeni||Switzerland|
|32||Interprofessional learning: impact on collaboration and attitudes towards health care teams||Bosnic-Anticevich||Australia|
|30||Comparing three different forms of interprofessional education on health professional inhaler technique and maintenance of correct technique||Bosnic-Anticevich||Australia|
|31||Asthma management and collaboration in primary care (Oral communication)||Bosnic-Anticevich||Australia|
|56||Medication Plan - feasibility in daily practice||Botermann||Germany|
|37||Initiation of a drug-drug interaction register for community pharmacies||Braun||Germany|
|11||Project SAFEMED: Pharmaceutical care for patients during admission and post-discharge||Brown||USA|
|13||Patients' willingness to re-use Home Medicanes Review and their perceptions of the listening skills of the interiewing pharmacist||Carter||Australia|
|14||Informal caregivers' willingness to use Home Medicines Review: Developing and testing the Knowledge Hassles Information Deeking Model (KHISM)||Carter||Australia|
|36||Adaptation and validation of a drug-related problem classification tool in community pharmacy (oral communication)||De Vriese||Belgium|
|29||Quality improvement through self evaluation: an online application for Belgian Community pharmacists||De Wulf||Belgium|
|35||Drug related problems and interventions of pharmacists on prescribed medicines||De Wulf||Belgium|
|5||Patients '"self-reconsiliation" of the medication list compared with medication verification with pharmacist||Ekedahl||Zweden|
|15||Challenges of information technologies adoption to enable community pharmacies eHealth services||Gregório||Portugal|
|8||Preventive care services in community pharmacies for improvement of cardiovascular risk factors - Evaluation by participants||Grote||Germany|
|3||Amsterdam Tool for Medication Review: Development and Validation||Hugtenburg||The Netherlands|
|47||Perception of patients of effectiveness and safety of treatments in relation to their knowledge of aim, dosing, duration and good utilization of their medication - The need of protocolized dispensing activity||Ibáñez||Spain|
|46||Determination of risk factors for drug related problems - A multidisciplinary triangulation process||Kaufmann||Switzerland|
|21||A review of clinical practice guidelines for the use of chronic non-malignant pain in primary care||Kennedy||Ireland|
|44||Patients' knowledge of pen-insulin therapy||Knjeginjic||Serbia|
|2||Patients' understanding of drug label instructions: a study among different populations living in the Netherlands||Kosters||The Netherlands|
|12||A novel instrument to measure medicines-related quality of life (Oral communication)||Krska||United Kingdom|
|28||Medication safety at a German University Hospital - results of a pilot project||Lenssen||Germany|
|20||Depression training involving consumer education: Impact on stigma toward people with depression||Liekens||Belgium|
|6||Medicine use review in Italy: a pilot project using asthma as model (reliminary data analysis)||Manfrin||United Kingdom|
|48||Collaborative development of outcome measures to investigate intermediate medication reviews provided in community pharmacies||Messerli||Switzerland|
|51||Role of resistance toerythropoietin stimulating agents in haemodialysis patients||Modamio||Spain|
|25||Defining professional pharmacy services - the role of community pharmacy||Moullin||Australia|
|52||Community pharmnacies: from dispensing drugs to pharmaceutical care. Actors involved in the wider health service network||Nadin||Italy|
|39||Prevalence, patterns and appropriateness of medicine use among an aging population with intellectual disability in Ireland||O'Dwyer||Ireland|
|7||Cost-effectiveness of a community pharmacist led sleep apnea screening ptogram - a Markov model||Perraudin||France|
|1||Pharmacist-physician relationships from pharmacist's perspective in Poland||Piecuch||Poland|
|45||Analyzing qualitatively graphic descriptors in a set of Portuguese medicine package inserts||Pires||Portugal|
|34||Cost-effectiveness analysis of pharmaceutical care in hypertension in Poland - Markov model||Polak||Poland|
|55||Review of hypertension medications in primary care||Ponjavic||Serbia|
|4||NetCare - a new telemedicine service in Swiss pharmacies||Rüggli||Switzerland|
|27||Predictors of masked hypertension in community pharmacy setting||Sabater||Australia|
|40||E-learning course: Medication therapy management||Schmid||Germany|
|41||Pharmacist' knowledge regarding medications safety during pregnancy||Tasic||Serbia|
|24||Do we inform/educate patients well about warfarin therapy||Tasic||Serbia|
|16||Development of decisions support systems to manage QT-prolongation in clinical practice||Vandael||Belgium|
|23||Establishing geriatric multidiciplinary out-patient clinic for medication review||Viktil||Norway|
|38||Case education||Vlcek||Czech Republic|
|22||Evaluation of a best practice model for multiprofessional medication management in cancer patients||Wilmer||Germany|
|33||Do we prescribe what patients prefer? A pilot study to assess patients' preferences for medication regimen characteristics||Witticke||Germany|
|26||Pharmaceutical care - can we influence the proper treatment for patient with diabetes||Yordanova||Bulgaria|
|49||Pharmaceutical and pharmacoeconomical assessment of the influence of diabetes on children||Yordanova||Bulgaria|